Fill Finish Manufacturing Market

Fill Finish Manufacturing Market by Product (Consumables (Prefilled Syringes (Glass, Plastic), Vial (Glass), Cartridge), Instrument (System (Stand alone, Integrated), Machine Type (Automated, Manual))), End User (CMO, Biopharma) - Global Forecasts to 2027

Report Code: PH 7648 Sep, 2022, by marketsandmarkets.com

The global fill finish manufacturing market size is projected to reach USD 15.2 billion by 2027, at a CAGR of 10.7% during the forecast period. Factors driving the market growth include rising growth of the biopharmaceutical industry, and the rising adoption of prefilled syringes for parenteral dosage forms.

Fill Finish Manufacturing Market

To know about the assumptions considered for the study, Request for Free Sample Report

Fill Finish Manufacturing Market Global Dynamics

Drivers: Rising technological advancements in fill-finish manufacturing processes

Technological advancements in aseptic fill-finish operations involve the usage of isolators and restricted-access barrier systems (RABS), which create robust sterile manufacturing environments that effectively separate human operators from the fill-finish process. Many equipment manufacturers in the fill finish manufacturing market are focusing on the development of barrier isolation systems, which are integrated fill-finish machines capable of carrying out all stages of fill-finish processes. In contrast to barrier isolation systems, standalone equipment used in fill-finish operations is both time-consuming and expensive, thus making the entire process complex and prone to contamination. The SA25 Aseptic Filling Workcell by Vanrx Pharma systems is an example of an isolated system. Owing to the benefits of isolators or RABS, many biopharmaceutical companies are adopting these machines in drug production facilities.

In traditional aseptic fill-finish processes, conventional stainless-steel systems require additional cleaning and sterilization (CIP/SIP), whereas a single-use system eliminates the critical steps of sterilization and further reduces the changeover time by simplifying end-of-batch breakdown and decontamination operations. Many pharmaceutical, biopharmaceutical, and contract manufacturing organizations are adopting single-use fill-finish systems, particularly for biologics. For instance, PreVAS (Syntegon Technology GmbH) is the first completely pre-validated, pre-assembled, and pre-sterilized single-use filling system available for vial, syringe, cartridge, and ampoule filling. This is mainly because single-use systems eliminate the need for sterilizing processes that are expensive and time-consuming. There are also economic advantages associated with single-use systems, such as the set-up and clean-down time being significantly reduced, thereby reducing labor costs. Single-use systems also help with a reduction in capital costs and chemicals used, along with minimizing utilities and water. The increasing pace of technological advancements in fill-finish manufacturing processes is positively driving the market growth.

Restraints: High costs associated with isolators/RABS

RABS and Isolators have advanced features and functionalities. The equipment provides an enclosed environment which reduces the risk of contamination. RABS and Isolators are priced high as compared to standalone systems. The average price of RABS and isolators is around USD 4.0 million to USD 8.0 million, which is high from standalone systems. In small companies this severely restricts their accessibility. The adoption of isolators and RABS is very low as compared to standalone systems in underdeveloped or developing countries. Standalone systems are still used in small pharmaceutical and biopharmaceutical companies, R&D laboratories, and academic institutes.

Opportunities: Emerging markets

Most of the global biomanufacturing is in North America, Western Europe, Ireland, and the UK. The emergence of global biosimilars licensure pathways has helped manufacturers expand capabilities by leveraging technologies aimed at minimizing costs and amortizing capital investments over multiple products. Rising standards of living across the globe and the desire of many governments to have local vaccines and sufficient biologics manufacturing to serve respective populations are driving the demand for the local production of biologics. This is a factor that will significantly drive the demand to expand biomanufacturing capabilities from the West to emerging markets. These economies include countries across Asia, Eastern Europe, South America, and Africa—specifically, India, China, Russia, Brazil, and Malaysia. Emerging markets such as India and China will provide lucrative opportunities for players functioning in this market. This can be mainly attributed to low labor and raw material costs, rising research activity, favorable government support, and technological integration & advancements.

Challenges: Challenges associated with maintaining sterility in fill- finish manufacturing operation

Aseptic fill-finish operations carry more risk than non-sterile processes. They require careful planning, trained personnel, and specialized facilities & equipments for process execution. Maintaining sterility is very important as any contamination can lead to huge financial losses and have immense effects on patients life. In aseptic fill-finishing processes all the components must be sterilized before use.

On the basis of product, the market is segmented into instruments and consumables. The consumables segment is further segmented into vials, cartridges, prefilled syringes and other consumables. The instruments segment is further divided into systems and machines. Machines are divided into automated and semi-automated machines. Systems, are further sub-segmented into integrated systems and standalone systems.

In 2021, the consumables segment dominated the market and is expected to be the fastest-growing segment during the forecast period. Factors driving the growth of segment include wide applications of vials in lyophilization, and the growing use of disposable packaging for biologics.

By end user, the contract manufacturing organizations segment is expected to witness the highest growth in the fill finish manufacturing market during the forecast period.

During the forecast period the contract manufacturing organizations segment is expected to show the highest growth due to rise in new entrants in the biologics manufacturing market and growing outsourcing of fill-finish manufacturing processes from small-sized biopharmaceutical companies.

Europe accounted for the largest market share during the forecast period.

The fill finish manufacturing market is divided into five major regions—Europe, North America, Asia Pacific, Latin America, and Middle East & Africa. In 2021, Europe accounted for the largest share of the global market, closely followed by North America. Factors responsible for growth in region include, growing incidence of chronic disorders, and the increasing focus of major players on increasing their presence in this region.

During the forecast period the Asia Pacific region is expected to witness the highest CAGR, mainly due to overall advancements in the biopharmaceutical industry, expertise & academic excellence and developments in R&D infrastructure in the Asia Pacific region.

Fill Finish Manufacturing Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Fill Finish Manufacturing Market Key Players

The major companies in the fill finish manufacturing market include Becton, Dickson and Company (US), Syntegon Technology GmbH (Germany), I.M.A. (Industria Macchine Automatiche) S.p.A. (Italy), Stevanato Group (Italy), West Pharmaceutical Services, Inc. (US), OPTIMA Packaging Group GmbH (Germany), Bausch+Strobel (Germany), Groninger & Co. GmbH (Germany), and Gerresheimer AG (Germany).

Syntegon Technology GmbH (Germany) is one of the leading players in the global fill finish manufacturing market. The company offers a broad product portfolio in the market through its machinery systems segment, which includes a wide range of automated standalone machines, integrated systems, and barrier systems such as isolator systems and RABS. The company also adopts organic strategies to maintain its position in this market. Over the years, isolators and RABS have witnessed increasing adoption by many pharmaceutical and biopharmaceutical companies to maintain high-quality product standards.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Values (USD Billion)

Segments covered

Product, End User, and Region

Geographies covered

North America (US, Canada), Europe (Germany, UK, France, and Rest of Europe), Asia Pacific (Japan, China, and Rest of Asia Pacific), Latin America and Middle East & Africa.

Top Companies covered

Becton, Dickson, and Company (US), Syntegon Technology GmbH (Germany), IMA Industria Macchine Automatiche S.p.A. (Italy), Stevanato Group (Italy), West Pharmaceutical Services, Inc. (US), OPTIMA packaging group GmbH (Germany), Bausch+Strobel (Germany), Groninger & Co.gmbh (Germany), Gerresheimer AG (Germany), SGD Pharma (France), SCHOTT AG (Germany), NIPRO (Japan), Bausch Advanced Technologies Group (US), Vanrx Pharmasystems Inc. (Canada), Maquinaria Industrial Dara, SL (Spain), Marchesini Group S.p.A. (Italy), Steriline S.r.l. (Italy), AST (US), Reagent Chemical & Research, Inc (US), Aseptic Technologies (Belgium).

This report categorizes the fill finish manufacturing market into the following segments and subsegments:

By product

  • Consumables
    • Prefilled Syringes
      • Glass PFS
      • Plastic PFS
    • Vials
      • Glass Vials
      • Plastic Vials
    • Cartridges
    • Other consumables (Ampoules, Bottles, IV Bags)
  • Instruments
    • Systems
      • Integrated Systems
      • Standalone Systems
    • Machine Type
      • Automated Machines
      • Semi-automated & Manual Machines

By End User

  • Pharmaceutical & Biopharmaceutical Companies
  • Contract Manufacturing Organizations
  • Other End Users such as Research & Development Laboratories and Academic Research Institutions

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • Rest of Asia Pacific
  • Latin America
  • Middle East & Africa

Recent developments:

  • In 2022, BD entered into an agreement with Mitsubishi Gas Chemical Company to investigate the further development of OXYCAPT, an innovation from MGC that integrates the best of plastic and glass for plastic syringes.
  • In 2021, West Pharmaceutical introduced the DeltaCube Modeling Platform and NovaGuard SA Pro Safety System for 0.5 mL standard glass syringes at Interphex.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 22)
    1.1 STUDY OBJECTIVES
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 STUDY SCOPE
           1.3.1 MARKETS COVERED
                    FIGURE 1 FILL FINISH MANUFACTURING MARKET SEGMENTATION
                    FIGURE 2 FILL-FINISH MANUFACTURING MARKET: GEOGRAPHIC SCOPE
           1.3.2 YEARS CONSIDERED
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY (Page No. - 26)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY DATA
           2.1.2 PRIMARY DATA
                    FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS
           2.1.3 DATA TRIANGULATION
                    FIGURE 4 DATA TRIANGULATION METHODOLOGY
    2.2 MARKET ESTIMATION METHODOLOGY
          FIGURE 5 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE-BASED ESTIMATION)
          FIGURE 6 MARKET SIZE ESTIMATION: APPROACH 2 (ESTIMATION BASED ON CONSUMABLE SEGMENTS)
    2.3 MARKET GROWTH RATE PROJECTIONS
          FIGURE 7 FILL FINISH MANUFACTURING MARKET: CAGR PROJECTIONS
          FIGURE 8 FILL-FINISH MANUFACTURING MARKET: CAGR PROJECTIONS FROM ANALYSIS OF DEMAND-SIDE DRIVERS, OPPORTUNITIES, RESTRAINTS, AND CHALLENGES
    2.4 RESEARCH ASSUMPTIONS

3 EXECUTIVE SUMMARY (Page No. - 32)
    FIGURE 9 FILL FINISH MANUFACTURING MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    FIGURE 10 FILL-FINISH MANUFACTURING MARKET SHARE, BY END USER, 2021
    FIGURE 11 GEOGRAPHICAL SNAPSHOT OF FILL-FINISH MANUFACTURING MARKET

4 PREMIUM INSIGHTS (Page No. - 35)
    4.1 FILL FINISH MANUFACTURING MARKET OVERVIEW
          FIGURE 12 RISING TECHNOLOGICAL ADVANCEMENTS IN FILL-FINISH MANUFACTURING PROCESSES TO DRIVE MARKET
    4.2 ASIA PACIFIC: FILL-FINISH MANUFACTURING MARKET, BY END USER AND COUNTRY (2021)
          FIGURE 13 CONTRACT MANUFACTURING ORGANIZATIONS ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC FILL-FINISH MANUFACTURING MARKET IN 2021
    4.3 FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY MACHINE TYPE, 2022 VS. 2027 (USD MILLION)
          FIGURE 14 AUTOMATED MACHINES WILL CONTINUE TO DOMINATE FILL-FINISH MANUFACTURING MARKET IN 2027
    4.4 FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
          FIGURE 15 PREFILLED SYRINGES SEGMENT DOMINATES FILL-FINISH CONSUMABLES MARKET IN 2022

5 MARKET OVERVIEW (Page No. - 38)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
          FIGURE 16 FILL FINISH MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS
           5.2.1 DRIVERS
                    5.2.1.1 Rising technological advancements in fill-finish manufacturing processes
                    5.2.1.2 Growth of biopharmaceutical industry
                    5.2.1.3 Rising adoption of prefilled syringes for parenteral dosage forms
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost associated with isolators/RABS
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Emerging markets
           5.2.4 CHALLENGES
                    5.2.4.1 Maintaining sterility in fill-finish manufacturing operations
           5.2.5 TRENDS
                    5.2.5.1 Growing outsourcing of fill-finish operations
                    5.2.5.2 Impact of COVID-19 on fill-finish manufacturing market

6 FILL FINISH MANUFACTURING MARKET, BY PRODUCT (Page No. - 43)
    6.1 INTRODUCTION
          TABLE 1 FILL-FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
    6.2 CONSUMABLES
          TABLE 2 FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 3 FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 4 NORTH AMERICA: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 5 EUROPE: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 6 ASIA PACIFIC: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.1 PREFILLED SYRINGES
                    TABLE 7 PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 8 PREFILLED SYRINGES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 9 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 10 EUROPE: PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 11 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.1 Glass prefilled syringes
                               6.2.1.1.1 Widespread use of glass syringes among end users to support market growth
                                              TABLE 12 GLASS PREFILLED SYRINGES MARKET, BY REGION, 2020–2027 (USD MILLION)
                                              TABLE 13 NORTH AMERICA: GLASS PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 14 EUROPE: GLASS PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 15 ASIA PACIFIC: GLASS PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    6.2.1.2 Plastic prefilled syringes
                               6.2.1.2.1 Plastic prefilled syringes to witness highest growth during forecast period
                                              TABLE 16 PLASTIC PREFILLED SYRINGES MARKET, BY REGION, 2020–2027 (USD MILLION)
                                              TABLE 17 NORTH AMERICA: PLASTIC PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 18 EUROPE: PLASTIC PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 19 ASIA PACIFIC: PLASTIC PREFILLED SYRINGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.2 VIALS
                    6.2.2.1 Glass vials
                               6.2.2.1.1 Growth in biologics market to drive demand
                    6.2.2.2 Plastic vials
                               6.2.2.2.1 Limitations associated with glass vials to support market growth
                                              TABLE 20 VIALS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                              TABLE 21 VIALS MARKET, BY REGION, 2020–2027 (USD MILLION)
                                              TABLE 22 NORTH AMERICA: VIALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 23 EUROPE: VIALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                              TABLE 24 ASIA PACIFIC: VIALS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.3 CARTRIDGES
                    6.2.3.1 High adoption among insulin manufacturers
                                TABLE 25 CARTRIDGES MARKET, BY REGION, 2020–2027 (USD MILLION)
                                TABLE 26 NORTH AMERICA: CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 27 EUROPE: CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                                TABLE 28 ASIA PACIFIC: CARTRIDGES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.4 OTHER CONSUMABLES
                    TABLE 29 OTHER CONSUMABLES MARKET, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 30 NORTH AMERICA: OTHER CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 31 EUROPE: OTHER CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 32 ASIA PACIFIC: OTHER CONSUMABLES MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 INSTRUMENTS
                    TABLE 33 FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION)
          TABLE 34 NORTH AMERICA: FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 35 EUROPE: FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 36 ASIA PACIFIC: FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.3.1 INSTRUMENTS, BY SYSTEM TYPE
                    6.3.1.1 Integrated systems
                               6.3.1.1.1 Help in increasing productivity
                    6.3.1.2 Standalone systems
                               6.3.1.2.1 Perform single operations such as cleaning and sterilizing
                                              TABLE 37 FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY SYSTEM TYPE, 2020–2027 (USD MILLION)
           6.3.2 INSTRUMENTS, BY MACHINE TYPE
                    6.3.2.1 Automated machines
                               6.3.2.1.1 Increase overall productivity for fill-finish manufacturing processes
                    6.3.2.2 Semi-automated and manual machines
                               6.3.2.2.1 Used for small-batch processing and lab trials
                                              TABLE 38 FILL-FINISH MANUFACTURING INSTRUMENTS MARKET, BY MACHINE TYPE, 2020–2027 (USD MILLION)

7 FILL FINISH MANUFACTURING MARKET, BY END USER (Page No. - 60)
    7.1 INTRODUCTION
          TABLE 39 FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
    7.2 CONTRACT MANUFACTURING ORGANIZATIONS
           7.2.1 GROWING PACE OF OUTSOURCING TO BENEFIT CMO SECTOR
                    TABLE 40 FILL-FINISH MANUFACTURING MARKET FOR CONTACT MANUFACTURING ORGANIZATIONS, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 41 EUROPE: FILL FINISH MANUFACTURING MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 42 NORTH AMERICA: FILL-FINISH MANUFACTURING MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 43 ASIA PACIFIC: FILL FINISH MANUFACTURING MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
           7.3.1 CURRENT MARKET SCENARIO INDICATES GREATER FOCUS ON DRUG R&D THAN ON FILL-FINISH SERVICES
                    TABLE 44 FILL FINISH MANUFACTURING MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2020–2027 (USD MILLION)
                    TABLE 45 EUROPE: FILL-FINISH MANUFACTURING MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 46 NORTH AMERICA: FILL FINISH MANUFACTURING MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
                    TABLE 47 ASIA PACIFIC: FILL-FINISH MANUFACTURING MARKET FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 OTHER END USERS
          TABLE 48 FILL FINISH MANUFACTURING MARKET FOR OTHER END USERS, BY REGION, 2020–2027 (USD MILLION)
          TABLE 49 NORTH AMERICA: FILL FINISH MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 50 EUROPE: FILL-FINISH MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 51 ASIA PACIFIC: FILL FINISH MANUFACTURING MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION)

8 FILL FINISH MANUFACTURING MARKET, BY REGION (Page No. - 67)
    8.1 INTRODUCTION
          TABLE 52 FILL FINISH MANUFACTURING MARKET, BY REGION, 2020–2027 (USD MILLION)
    8.2 EUROPE
          FIGURE 17 EUROPE: FILL-FINISH MANUFACTURING MARKET SNAPSHOT
          TABLE 53 EUROPE: FILL FINISH MANUFACTURING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 54 EUROPE: FILL-FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 55 EUROPE: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 56 EUROPE: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 57 EUROPE: FILL-FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.2.1 GERMANY
                    8.2.1.1 Germany to witness highest growth in Europe
                                TABLE 58 GERMANY: FILL FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 USD MILLION)
                                TABLE 59 GERMANY: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 60 GERMANY: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 61 GERMANY: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.2.2 FRANCE
                    8.2.2.1 Increasing focus on developing biologics to drive demand for fill-finish technologies
                                TABLE 62 FRANCE: FILL-FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 63 FRANCE: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 64 FRANCE: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 65 FRANCE: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.2.3 UK
                    8.2.3.1 Growth in biopharmaceutical industry to support market growth
                                TABLE 66 UK: FILL-FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 67 UK: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 68 UK: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 69 UK: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.2.4 REST OF EUROPE
                    TABLE 70 REST OF EUROPE: FILL-FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 71 REST OF EUROPE: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 72 REST OF EUROPE: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 73 REST OF EUROPE: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.3 NORTH AMERICA
          TABLE 74 NORTH AMERICA: FILL-FINISH MANUFACTURING MARKET, BY COUNTRY, 2020–2027 USD MILLION)
          TABLE 75 NORTH AMERICA: FILL FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 76 NORTH AMERICA: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 77 NORTH AMERICA: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 78 NORTH AMERICA: FILL-FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.3.1 US
                    8.3.1.1 Growth in biopharmaceutical research and development activities to drive market
                                TABLE 79 US: FILL FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 80 US: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 81 US: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 82 US: FILL-FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.3.2 CANADA
                    8.3.2.1 Rising government focus on developing patented medicines to boost market growth
                                TABLE 83 CANADA: FILL FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 84 CANADA: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 85 CANADA: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 86 CANADA: FILL-FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.4 ASIA PACIFIC
          FIGURE 18 ASIA PACIFIC: FILL-FINISH MANUFACTURING MARKET SNAPSHOT
          TABLE 87 ASIA PACIFIC: FILL FINISH MANUFACTURING MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 88 ASIA PACIFIC: FILL-FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
          TABLE 89 ASIA PACIFIC: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 90 ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 91 ASIA PACIFIC: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.4.1 CHINA
                    8.4.1.1 Fastest-growing market for fill-finish manufacturing in Asia Pacific
                                TABLE 92 CHINA: FILL-FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 93 CHINA: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 94 CHINA: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 95 CHINA: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.4.2 JAPAN
                    8.4.2.1 Rising geriatric population and growth in biosimilars market—key growth drivers
                                TABLE 96 JAPAN: FILL-FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                                TABLE 97 JAPAN: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 98 JAPAN: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 99 JAPAN: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
           8.4.3 REST OF ASIA PACIFIC
                    TABLE 100 REST OF ASIA PACIFIC: FILL-FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 101 REST OF ASIA PACIFIC: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 102 REST OF ASIA PACIFIC: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 103 REST OF ASIA PACIFIC: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.5 LATIN AMERICA
           8.5.1 INCREASING NUMBER OF BIOMANUFACTURING PLANTS TO DRIVE DEMAND FOR FILL-FINISH MACHINES AND CONSUMABLES
                    TABLE 104 LATIN AMERICA: FILL-FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 105 LATIN AMERICA: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 106 LATIN AMERICA: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 107 LATIN AMERICA: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.6 MIDDLE EAST AND AFRICA
           8.6.1 GROWTH IN BIOPHARMACEUTICALS TO DRIVE MARKET
                    TABLE 108 MIDDLE EAST AND AFRICA: FILL FINISH MANUFACTURING MARKET, BY PRODUCT, 2020–2027 (USD MILLION)
                    TABLE 109 MIDDLE EAST AND AFRICA: FILL-FINISH MANUFACTURING CONSUMABLES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 110 MIDDLE EAST AND AFRICA: PREFILLED SYRINGES MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 111 MIDDLE EAST AND AFRICA: FILL FINISH MANUFACTURING MARKET, BY END USER, 2020–2027 (USD MILLION)

9 COMPETITIVE LANDSCAPE (Page No. - 94)
    9.1 OVERVIEW
    9.2 STRATEGIES ADOPTED BY KEY PLAYERS/RIGHT TO WIN
          TABLE 112 KEY DEVELOPMENTS IN FILL FINISH MANUFACTURING MARKET, 2019–2022
    9.3 FILL FINISH MANUFACTURING MARKET SHARE ANALYSIS
          FIGURE 19 COMPANY RANKING IN FILL-FINISH CONSUMABLES MARKET, 2021
          FIGURE 20 MARKET SHARE ANALYSIS IN FILL-FINISH INSTRUMENTS MARKET, 2021
    9.4 COMPANY EVALUATION QUADRANT
           9.4.1 STARS
           9.4.2 EMERGING LEADERS
           9.4.3 PERVASIVE PLAYERS
           9.4.4 PARTICIPANTS
                    FIGURE 21 FILL FINISH MANUFACTURING MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
    9.5 COMPETITIVE SITUATION AND TRENDS
    9.6 COMPETITIVE SCENARIO
          TABLE 113 PRODUCT LAUNCHES
          TABLE 114 DEALS

10 COMPANY PROFILES (Page No. - 102)
     10.1 MAJOR PLAYERS
(Business Overview, Products & Services Offered, Recent Developments, and MnM View)*
             10.1.1 SYNTEGON TECHNOLOGY GMBH
                        TABLE 115 SYNTEGON TECHNOLOGY GMBH: BUSINESS OVERVIEW
             10.1.2 I.M.A. (INDUSTRIA MACCHINE AUTOMATICHE) S.P.A
                        TABLE 116 I.M.A. (INDUSTRIA MACCHINE AUTOMATICHE) S.P.A: BUSINESS OVERVIEW
             10.1.3 BECTON, DICKINSON AND COMPANY (BD)
                        TABLE 117 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW
                        FIGURE 22 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2021)
             10.1.4 STEVANATO GROUP
                        TABLE 118 STEVANATO GROUP: BUSINESS OVERVIEW
                        FIGURE 23 STEVANATO GROUP: COMPANY SNAPSHOT (2021)
             10.1.5 WEST PHARMACEUTICAL SERVICES
                        TABLE 119 WEST PHARMACEUTICAL SERVICES: BUSINESS OVERVIEW
                        FIGURE 24 WEST PHARMACEUTICAL SERVICES: COMPANY SNAPSHOT (2021)
             10.1.6 OPTIMA PACKAGING GROUP GMBH
                        TABLE 120 OPTIMA PACKAGING GROUP GMBH: BUSINESS OVERVIEW
             10.1.7 BAUSCH+STRÖBEL
                        TABLE 121 BAUSCH+STRÖBEL: BUSINESS OVERVIEW
             10.1.8 GRONINGER & CO. GMBH
                        TABLE 122 GRONINGER & CO. GMBH: BUSINESS OVERVIEW
             10.1.9 SGD PHARMA
                        TABLE 123 SGD PHARMA: BUSINESS OVERVIEW
             10.1.10 SCHOTT AG
                        TABLE 124 SCHOTT AG: BUSINESS OVERVIEW
                        FIGURE 25 SCHOTT AG: COMPANY SNAPSHOT (2021)
             10.1.11 GERRESHEIMER AG
                        TABLE 125 GERRESHEIMER AG: BUSINESS OVERVIEW
                        FIGURE 26 GERRESHEIMER AG: COMPANY SNAPSHOT (2021)
             10.1.12 NIPRO CORPORATION
                        TABLE 126 NIPRO CORPORATION: BUSINESS OVERVIEW
                        FIGURE 27 NIPRO CORPORATION: COMPANY SNAPSHOT (2021)
             10.1.13 BAUSCH ADVANCED TECHNOLOGY GROUP
                        TABLE 127 BAUSCH ADVANCED TECHNOLOGY GROUP: BUSINESS OVERVIEW
             10.1.14 VANRX PHARMASYSTEMS INC.
                        TABLE 128 VANRX PHARMASYSTEMS INC.: BUSINESS OVERVIEW
             10.1.15 MAQUINARIA INDUSTRIAL DARA SL
                        TABLE 129 MAQUINARIA INDUSTRIAL DARA SL: BUSINESS OVERVIEW
* Business Overview, Products & Services Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
     10.2 OTHER COMPANIES
             10.2.1 MARCHESINI GROUP S.P.A.
                        TABLE 130 MARCHESINI GROUP S.P.A.: COMPANY OVERVIEW
             10.2.2 STERILINE S.R.L
                        TABLE 131 STERILINE S.R.L: COMPANY OVERVIEW
             10.2.3 AST
                        TABLE 132 AST: COMPANY OVERVIEW
             10.2.4 REAGENT CHEMICAL & RESEARCH, INC.
                        TABLE 133 REAGENT CHEMICAL & RESEARCH, INC.: COMPANY OVERVIEW
             10.2.5 ASEPTIC TECHNOLOGIES
                        TABLE 134 ASEPTIC TECHNOLOGIES: COMPANY OVERVIEW

11 APPENDIX (Page No. - 150)
     11.1 DISCUSSION GUIDE
     11.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     11.3 CUSTOMIZATIONS OPTIONS
     11.4 RELATED REPORTS
     11.5 AUTHOR DETAILS

The study involved two major activities in estimating the current market size of the fill-finish manufacturing market. Exhaustive research was conducted to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

The secondary sources referred for this research study include publications from government sources, such as the World Health Organization (WHO), US Food and Drug Administration (FDA), National Institutes of Health (NIH), International Society for Pharmaceutical Engineering (ISPE), Parenteral Drug Association (PDA), BioPharm International, and the National Center for Biotechnology Information (NCBI). Secondary sources also include corporate and regulatory filings (such as annual reports, SEC filings, investor presentations, and financial statements); business magazines & research journals; press releases; and trade, business, and professional associations, among others. Secondary data was collected and analyzed to arrive at the overall size of the global fill-finish manufacturing market, which was validated through primary research. The key secondary sources referred to during the preparation of this report are listed below:

Government and Intergovernmental Sources & Databases: World Health Organization (WHO), US Food and Drug Administration (FDA), National Institutes of Health (NIH), International Society for Pharmaceutical Engineering (ISPE), Parenteral Drug Association (PDA), BioPharm International, and the National Center for Biotechnology Information (NCBI), among others.

Company Sources: Annual reports, SEC filings, regulatory filings, investor presentations, press releases, and financial statements, among others.

Background Study

  • Building a basic understanding of the fill-finish manufacturing market
  • Analyzing the MarketsandMarkets data repository, followed by drawing and updating data tables using current information
  • Identifying data gaps and key global players in product and end user segments

Market Understanding

  • Identifying stakeholders and key decision-makers in different regions
  • Identifying the selection criteria of key decision-makers
  • Analyzing the competitive landscape
  • Identifying major players with their product portfolios
  • Analyzing strategies adopted by players to position different types of products
  • Analyzing the regional/country-level markets

Trends

  • Identifying and analyzing key products and trends to draw notes and include considerations in the final forecasts
  • Identifying the major drivers, opportunities, and challenges prevailing in the fill-finish manufacturing market
  • Identifying industry trends
  • Analyzing the regulatory landscape

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global fill-finish manufacturing market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (such as personnel from biopharma & pharma companies, clinical laboratories, and academic & research institutes; and purchase managers in healthcare provider organizations) and supply-side (such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners, among others) across four major regions—North America, Europe, the Asia Pacific, Latin America, and Middle East & Africa. Approximately 70% and 30% of primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews. A breakup is provided below:

Fill Finish Manufacturing Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The revenue-based approach individually for instrument and consumable segments was used to estimate the global market size of the fill-finish manufacturing market.

Data Triangulation

After arriving at the overall market size—using the market size estimation processes explained above—the fill-finish manufacturing market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides of the sterile filtration market.

Report Objectives

  • To define, describe, segment, and forecast the global fill-finish manufacturing market by product, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market such as drivers, restraints, opportunities, industry-specific challenges, and trends
  • To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall fill-finish manufacturing market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
  • To forecast the size of the fill-finish manufacturing market with respect to five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
  • To strategically profile the key players in the market and comprehensively analyze their market rankings and core competencies
  • To track and analyze competitive developments such as acquisitions, agreements, collaborations, partnerships, product launches, and expansions in the fill-finish manufacturing market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the fill-finish manufacturing market report:

Product Analysis

  • Product matrix, which gives a detailed comparison of the product portfolios of the top five companies

Geographic Analysis

  • Further breakdown of Latin America o Brazil and Mexico
  • Further breakdown of the European fill-finish manufacturing market into Spain and Italy

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5)
Report Code
PH 7648
Published ON
Sep, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Fill Finish Manufacturing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback